M. Marty

8.7k citations
127 papers · 6.1k · 1 hit paper · h-index 40

Impact in

  • Biotechnology top 0.2%
    • Microbial Inactivation Methods
  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • Cancer Treatment and Pharmacology 34
    • Colorectal Cancer Treatments and Studies 13
    • HER2/EGFR in Cancer Research 7
    • Cancer Cells and Metastasis 6
    • Neutropenia and Cancer Infections 6
    • Breast Cancer Treatment Studies 22
    • Cancer Genomics and Diagnostics 7

M. Marty

122 papers receiving 5.9k citations

M. Marty's Hit Papers

Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study 2006 · 638 citations
6380+6+13Years since publication200400600

Peers

M. Marty
Comparison fields: 5 of 125
  • Biotechnology 1.1k
  • Oncology 2.6k
  • Cancer Research 1.0k
  • Immunology 476
  • Pulmonary and Respiratory Medicine 677
Replace Anish Thomas with:
Anish Thomas United States
Ronald C. DeConti United States
Frances A. Collichio United States
Chris Twelves United Kingdom
Dick J. Richel Netherlands
Tetsuro Kubota Japan
Claire F. Verschraegen United States
David Khayat France
Martin N. Raber United States
Torben Skovsgaard Denmark
M. Marty relative to Anish Thomas United States Anish Thomas's profile →
Citations per field
00.5×1.5×2.1×
Anish Thomas · 1×
Citations per year

Countries citing papers authored by M. Marty

Since Specialization
Citations

This map shows the geographic impact of M. Marty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Marty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Marty more than expected).

Fields of papers citing papers by M. Marty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Marty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Marty. The network helps show where M. Marty may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Marty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Marty Line = papers co-authored together M. Marty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
Hit paper breakdown →
2006638
2 2006438
3 1996332
4 1990294
5
The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.
1992239
6
Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.
1993227
7 2009190
8 2004189
9 2008154
10 2006148
11 2001136
12 2001134
13
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.
1994134
14 2007132
15 1996130
16 2007127
17 1999111
18 201086
19 201281
20 200379

About M. Marty

M. Marty is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, having authored 127 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (34 papers), Breast Cancer Treatment Studies (22 papers), Colorectal Cancer Treatments and Studies (13 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Cells and Metastasis (6 papers), Neutropenia and Cancer Infections (6 papers) and Chemotherapy-related skin toxicity (5 papers). The work is most often cited by research in Biotechnology (1.1k citations), Oncology (2.6k citations), Cancer Research (1.0k citations), Immunology (476 citations) and Pulmonary and Respiratory Medicine (677 citations). M. Marty has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Marc Espié, Jean Marc Extra, Fabien Calvo, Lluis M. Mir, Julie Gehl, Z Rudolf, Gregor Serša, Gerald C. O’Sullivan, Poul Geertsen and Chris Collins. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact